NeuroPace Inc (NPCE) USD0.001

Sell:$14.00Buy:$16.92Price increased$0.64 (3.93%)

Market closed |
Prices delayed by at least 15 minutes
Sell:$14.00
Buy:$16.92
Change:Price increased$0.64 (3.93%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$14.00
Buy:$16.92
Change:Price increased$0.64 (3.93%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.

Key people

Frank M. Fischer
Independent Chairman of the Board
Joel D. Becker
President, Chief Executive Officer, Director
Patrick F. Williams
Chief Financial Officer
Martha J. Morrell
Chief Medical Officer
Lisa Andrade
Independent Director
Uri Geiger
Independent Director
R. Scott Huennekens
Independent Director
Rakhi Kumar
Independent Director
Click to see more

Key facts

  • Shares in issue
    34.09m
  • EPIC
    NPCE
  • ISIN
    US6412881053
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $576.87m
  • Employees
    220
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.